Therefore, in order to identify ACE I/D gene polymorphism as a predictor for RVO, ACE allele frequency in healthy individuals and ACE gene polymorphism frequency in patients with essential hypertension and type 2 diabetes mellitus should be considered in the population studied [28,29]. Here, ACE is linked to essential hypertension.